CClinicalTrials.gg
CompletedNCT05444140Updated Jul 5, 2022

A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk

An interventional study of Health coaching in Cardiometabolic Disease, Health Coaching and Middle-aged Adults, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 40 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-05.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Apr 2021, registered Jun 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
40 Years to 64 Years
Sex
All
01

Study summary

Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.

Read the detailed description

A single group pretest-posttest feasibility study was conducted. The health coaching programme included four monthly health coaching sessions for three months. Feasibility of the study was measured by eligibility rate, enrollment rate, adherence rate, and attrition rate. Intervention acceptability was measured by satisfactory survey after completion of health coaching intervention. Feasibility of outcome measures was measured by the completion of outcome measures assessment at baseline and 6 months after enrollment.

02

Conditions studied

  • Cardiometabolic Disease
  • Health Coaching
  • Middle-aged Adults
  • Primary Prevention

Keywords

  • cardiometabolic disease
  • feasibility study
  • health coaching
  • middle-aged adults
  • primary prevention
03

In context

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • aged 40-64 years;
  • have a non-laboratory INTERHEART risk score (IHRS) of 16 or higher;
  • can communicate in Cantonese;
  • able to give informed consent.

Exclusion criteria

Exclusion Criteria:

  • previous diagnosis of transient ischemic attack, stroke, myocardial infarction, atrial fibrillation, coronary heart disease, heart failure, dementia, chronic renal failure and diabetes;
  • currently on medication to control hyperlipidemia, diabetes or hypertension;
  • with eye or retinal disease;
  • diagnosis of terminal disease with an expected life expectancy less than 12 months;
  • currently participating in any other clinical trial;
  • currently participating in any other structured lifestyle-based or exercise-based programme.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Experimental group

    Health coaching

    Behavioral: Health coaching

Interventions

  • BehavioralHealth coaching

    The health coaching programme includes four monthly health coaching sessions for three months.

06

What researchers measure

Primary outcomes

  1. Feasibility of study

    eligibility rate, enrolment rate

    Time frame: at baseline

  2. Feasibility of study

    adherence rate

    Time frame: at 3 months after enrolment

  3. Feasibility of study

    attrition rate

    Time frame: at 3 months after enrolment

  4. Feasibility of study

    attrition rate

    Time frame: at 6 months after enrolment

  5. Intervention Acceptability

    Participants' satisfaction survey

    Time frame: at 3 months after enrolment

  6. Feasibility of outcome measures assessment

    completion rate of a battery of outcome measures assessment (including (1) health promoting behaviours measures using Health Promoting Lifestyle Profile II (HPLP II); (2) cardiometabolic risk measured using non-laboratory INTERHEART risk score and the Automatic Retinal Image Analysis (ARIA)-stroke model; (3) self-efficacy of adopting health-promoting behaviours measured using Diabetes Mellitus Type II Self Efficacy Scale; (4) psychological distress measured using the Chinese version of the shorter version of Depression Anxiety Stress Scales (DASS); (5) sleep quality measured using the Chinese version of the Pittsburg Sleep Quality Index; (6) physical activity level measured using the International Physical Activity Questionnaire-Chinese (IPAQ-C); and (7) physiological parameters, including blood pressure, body mass index (BMI), waist-hip-ratio (WHR) and point of care blood test for glucose, lipid and urate level)

    Time frame: at baseline

  7. Feasibility of outcome measures assessment

    completion rate of a battery of outcome measures assessment (including (1) health promoting behaviours measures using Health Promoting Lifestyle Profile II (HPLP II); (2) cardiometabolic risk measured using non-laboratory INTERHEART risk score and the Automatic Retinal Image Analysis (ARIA)-stroke model; (3) self-efficacy of adopting health-promoting behaviours measured using Diabetes Mellitus Type II Self Efficacy Scale; (4) psychological distress measured using the Chinese version of the shorter version of Depression Anxiety Stress Scales (DASS); (5) sleep quality measured using the Chinese version of the Pittsburg Sleep Quality Index; (6) physical activity level measured using the International Physical Activity Questionnaire-Chinese (IPAQ-C); and (7) physiological parameters, including blood pressure, body mass index (BMI), waist-hip-ratio (WHR) and point of care blood test for glucose, lipid and urate level)

    Time frame: at 6 months after enrolment

07

Study locations

1 site
  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05444140
Lead sponsor
Chinese University of Hong Kong
Responsible party
Zoe Ching Man Kwok (Lecturer, Chinese University of Hong Kong) — Principal investigator
First posted
Jul 5, 2022
Start date
Apr 1, 2021
Primary completion
Nov 13, 2021
Completion
Nov 13, 2021
Last update
Jul 5, 2022

Study contacts

Zoe Kwok
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion